Showing results (2211-2220 of 10,589) with videos related to
Sort By:
Pageof 1,059
Thrombosis Research|September 7, 2014
Active PAI-1 as marker for venous thromboembolism: case-control study using a comprehensive panel of PAI-1 and TAFI assaysLize Bollen, Marijke Peetermans, Miet Peeters, et al.Thrombosis Research|July 10, 2014
Treatment of epistaxis in hereditary hemorrhagic telangiectasia with tranexamic acid - a double-blind placebo-controlled cross-over phase IIIB studyUrban W Geisthoff, Ulrich T Seyfert, Marcus Kübler, et al.Thrombosis Research|October 15, 2014
Thrombosis: a major contributor to global disease burdenThrombosis Research|August 16, 2014
Serum soluble CD40 Ligand levels are associated with severity and mortality of brain trauma injury patientsLeonardo Lorente, María M Martín, Agustín F González-Rivero, et al.Thrombosis Research|December 15, 1989
Plasmin-a2-plasmin inhibitor complex in plasma of patients with thromboembolic diseasesK Wada, H Takahashi, W Tatewaki, et al.Thrombosis Research|October 9, 2014
Ex vivo and in vivo studies of CME-1, a novel polysaccharide purified from the mycelia of Cordyceps sinensis that inhibits human platelet activation by activating adenylate cyclase/cyclic AMPWan-Jung Lu, Nen-Chung Chang, Thanasekaran Jayakumar, et al.Thrombosis Research|October 9, 2014
Safety and efficacy of edoxaban, an oral factor Xa inhibitor, versus enoxaparin for thromboprophylaxis after total knee arthroplasty: the STARS E-3 trialTakeshi Fuji, Ching-Jen Wang, Satoru Fujita, et al.Thrombosis Research|December 2, 2014
Incidence of symptomatic venous thromboembolism in patients with hemophilia undergoing joint replacement surgery: a retrospective studyJuliana Perez Botero, Daniel B Spoon, Mrinal S Patnaik, et al.Thrombosis Research|December 3, 2014
Synergistic effect of signaling from receptors of soluble platelet agonists and outside-in signaling in formation of a stable fibrinogen-integrin αIIbβ3-actin cytoskeleton complexIvan Budnik, Boris Shenkman, Naphtali SavionThrombosis Research|December 3, 2014
A meta-analysis of phase III randomized controlled trials with novel oral anticoagulants in atrial fibrillation: comparisons between direct thrombin inhibitors vs. factor Xa inhibitors and different dosing regimensRui Providência, Erik Lerkevang Grove, Steen Husted, et al.Pageof 1,059